-+ 0.00%
-+ 0.00%
-+ 0.00%

NEUROONE MEDICAL TECHNOLOGIES CORP - RESTATEMENT DOES NOT AFFECT FY2026 PRODUCT REVENUE GUIDANCE OR CASH POSITION - SEC FILING

Reuters·05/22/2026 21:13:25

Please log in to view news